The FDA has approved the use of scorpion-derived venom in human trials on brain cancer patients. Really. The re-engineered protein from the scorpion is mixed with a fluorescent molecule "flashlight;" the product, called “tumor paint,” illuminates tumors or areas so small a physician may be…
Spokesman-Review features writer Rebecca Nappi, along with writer Catherine Johnston of Olympia, Wash., discuss here issues facing aging boomers, seniors and those experiencing serious illness, dying, death and other forms of loss.
